Neuberger Berman Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $38.8M | Sell |
|
|||||
|
2025
Q2 | $146M | Sell |
|
|||||
|
2025
Q1 | $275M | Buy |
|
|||||
|
2024
Q4 | $150M | Buy |
|
|||||
|
2024
Q3 | $93.2M | Buy |
|
|||||
|
2024
Q2 | $24.3M | Buy |
|
|||||
|
2024
Q1 | $30.2M | Sell |
|
|||||
|
2023
Q4 | $155M | Sell |
|
|||||
|
2023
Q3 | $316M | Sell |
|
|||||
|
2023
Q2 | $352M | Sell |
|
|||||
|
2023
Q1 | $408M | Buy |
|
|||||
|
2022
Q4 | $415M | Buy |
|
|||||
|
2022
Q3 | $321M | Sell |
|
|||||
|
2022
Q2 | $372M | Buy |
|
|||||
|
2022
Q1 | $276M | Buy |
|
|||||
|
2021
Q4 | $186M | Sell |
|
|||||
|
2021
Q3 | $224M | Sell |
|
|||||
|
2021
Q2 | $253M | Buy |
|
|||||
|
2021
Q1 | $148M | Sell |
|
|||||
|
2020
Q4 | $181M | Buy |
|
|||||
|
2020
Q3 | $170M | Sell |
|
|||||
|
2020
Q2 | $193M | Sell |
|
|||||
|
2020
Q1 | $189M | Sell |
|
|||||
|
2019
Q4 | $222M | Buy |
|
|||||
|
2019
Q3 | $120M | Sell |
|
|||||
|
2019
Q2 | $121M | Sell |
|
|||||
|
2019
Q1 | $130M | Buy |
|
|||||
|
2018
Q4 | $110M | Buy |
|
|||||
|
2018
Q3 | $109M | Sell |
|
|||||
|
2018
Q2 | $137M | Sell |
|
|||||
|
2018
Q1 | $195M | Sell |
|
|||||
|
2017
Q4 | $194M | Buy |
|
|||||
|
2017
Q3 | $181M | Sell |
|
|||||
|
2017
Q2 | $225M | Sell |
|
|||||
|
2017
Q1 | $248M | Sell |
|
|||||
|
2016
Q4 | $320M | Sell |
|
|||||
|
2016
Q3 | $309M | Buy |
|
|||||
|
2016
Q2 | $407M | Sell |
|
|||||
|
2016
Q1 | $390M | Buy |
|
|||||
|
2015
Q4 | $412M | Sell |
|
|||||
|
2015
Q3 | $364M | Sell |
|
|||||
|
2015
Q2 | $421M | Buy |
|
|||||
|
2015
Q1 | $406M | Sell |
|
|||||
|
2014
Q4 | $422M | Sell |
|
|||||
|
2014
Q3 | $390M | Sell |
|
|||||
|
2014
Q2 | $426M | Buy |
|
|||||
|
2014
Q1 | $448M | Sell |
|
|||||
|
2013
Q4 | $503M | Sell |
|
|||||
|
2013
Q3 | $442M | Buy |
|
|||||
|
2013
Q2 | $403M | Buy |
|